Despite positive net inflows; equity funds experienced the bulk of the price depletion in January 2025
At 3.0%, the US consumer inflation is a full 100 bps above the Fed target of 2.0%, reducing further rate cut hopes
The IIP growth for December was subdued at 3.22%, but previous revisions have been a mixed bag
While food inflation is perceptibly lower in January 2025, there has been a rebound in core inflation
A look at what stocks the Big-10 Mutual Fund Houses are buying and selling in January 2025
On a consolidated basis, revenue rose 6.7% YoY to ₹2.40 lakh crore, up from ₹2.25 lakh crore in the corresponding quarter last year.
Here are some of the stocks that may see significant price movement today: Paytm, Bank of Baroda, Kalpataru Project, etc.
EBITDA came in at ₹100.1 crore down 9.6% YoY compared to ₹110.7 crore reflecting operating margin pressure.
Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.
EBITDA margin improved to 11.2% vs. 9.7% last year, reflecting better cost management and higher profitability.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
